Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
K36 Therapeutics, Inc.
Alterome Therapeutics, Inc.
Eli Lilly and Company
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Eli Lilly and Company
Angiex, Inc.
Werewolf Therapeutics, Inc.
MacroGenics
Adaptimmune
Astellas Pharma Inc
ARTBIO Inc.
Eli Lilly and Company
IDEAYA Biosciences
HiberCell, Inc.
Memorial Sloan Kettering Cancer Center
OncoNano Medicine, Inc.
City of Hope Medical Center
MOMA Therapeutics
GlaxoSmithKline
Sairopa B.V.
AccSalus Biosciences, Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Incyte Corporation
M.D. Anderson Cancer Center
Nurix Therapeutics, Inc.
Kazia Therapeutics Limited
Pfizer
Incyte Corporation
Trishula Therapeutics, Inc.
University of California, San Francisco
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NextPoint Therapeutics, Inc.
Exelixis
Zhejiang University
Orion Biotechnology Polska Sp. z o.o.
Daiichi Sankyo
Astellas Pharma Inc
Carisma Therapeutics Inc
Acepodia Biotech, Inc.
Astellas Pharma Inc
Pfizer
Pfizer
University of Utah
Pfizer